Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015 | Journal of the American College of Cardiology | 2017 | 1.8K |
Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015 | JAMA - Journal of the American Medical Association | 2017 | 957 |
Non-specific low back pain | Lancet, The | 2017 | 849 |
Exercise to prevent falls in older adults: an updated systematic review and meta-analysis | British Journal of Sports Medicine | 2017 | 436 |
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy | Lancet, The | 2017 | 419 |
Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial | Lancet, The | 2017 | 348 |
Association of Postoperative High-Sensitivity Troponin Levels With Myocardial Injury and 30-Day Mortality Among Patients Undergoing Noncardiac Surgery | JAMA - Journal of the American Medical Association | 2017 | 320 |
Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials | Lancet Diabetes and Endocrinology,the | 2017 | 258 |
Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment | Nature Reviews Nephrology | 2017 | 242 |
Canagliflozin Slows Progression of Renal Function Decline Independently of Glycemic Effects | Journal of the American Society of Nephrology: JASN | 2017 | 220 |
Child and Adolescent Health From 1990 to 2015: Findings From the Global Burden of Diseases, Injuries, and Risk Factors 2015 Study | JAMA Pediatrics | 2017 | 216 |
Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial | JAMA - Journal of the American Medical Association | 2017 | 214 |
Association of Positive Airway Pressure With Cardiovascular Events and Death in Adults With Sleep Apnea: A Systematic Review and Meta-analysis | JAMA - Journal of the American Medical Association | 2017 | 192 |
Genome-wide association analyses of sleep disturbance traits identify new loci and highlight shared genetics with neuropsychiatric and metabolic traits | Nature Genetics | 2017 | 182 |
Omega-6 fatty acid biomarkers and incident type 2 diabetes: pooled analysis of individual-level data for 39 740 adults from 20 prospective cohort studies | Lancet Diabetes and Endocrinology,the | 2017 | 150 |
The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics | American Journal of Nephrology | 2017 | 149 |
The prevalence of food allergy and other allergic diseases in early childhood in a population-based study: HealthNuts age 4-year follow-up | Journal of Allergy and Clinical Immunology | 2017 | 146 |
Sex differences in coronary heart disease and stroke mortality: a global assessment of the effect of ageing between 1980 and 2010 | BMJ Global Health | 2017 | 140 |
Global Cardiovascular and Renal Outcomes of Reduced GFR | Journal of the American Society of Nephrology: JASN | 2017 | 127 |
A cardiac contouring atlas for radiotherapy | Radiotherapy and Oncology | 2017 | 126 |
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes | New England Journal of Medicine | 2017 | 123 |
Comparative prognostic performance of definitions of prediabetes: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study | Lancet Diabetes and Endocrinology,the | 2017 | 114 |
Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study-Renal (CANVAS-R): A randomized, placebo-controlled trial | Diabetes, Obesity and Metabolism | 2017 | 101 |
Non-steroidal anti-inflammatory drugs for spinal pain: a systematic review and meta-analysis | Annals of the Rheumatic Diseases | 2017 | 98 |
Linagliptin and its effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: the randomized MARLINA-T2D trial | Diabetes, Obesity and Metabolism | 2017 | 98 |